Prevalence of vomiting and nausea and associated factors after chronic and acute gluten exposure in celiac disease.
Celiac disease
Gluten challenge
Nausea
Vomiting
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
06 Sep 2023
06 Sep 2023
Historique:
received:
06
06
2023
accepted:
25
08
2023
medline:
8
9
2023
pubmed:
7
9
2023
entrez:
6
9
2023
Statut:
epublish
Résumé
Vomiting and nausea seem to be relatively specific symptoms related to gluten ingestion in treated celiac disease. However, the overall prevalence and associated factors of these symptoms after chronic gluten exposure at celiac disease diagnosis and acute re-exposure during gluten challenge remain obscure. Medical data on 815 adult celiac disease patients were collected at diagnosis from the medical records and through supplementary interviews. An additional 74 patients underwent a three-day (10 g/day) gluten challenge (wheat, barley, rye or a combination of the three grains) while in remission. Prevalence of vomiting/nausea and associated factors were evaluated in both cohorts. A literature review was conducted to summarize earlier studies. Twenty-eight (3%) patients presented with vomiting at diagnosis. They were less often screen-detected and suffered from extra-intestinal symptoms, and had more often abdominal pain (71% vs. 49%, p = 0.021), diarrhea (61% vs. 40%, p = 0.031), weight loss (36% vs. 17%, p = 0.019) and childhood symptoms (61% vs. 33%, p = 0.002) than those without vomiting (n = 787). The groups were comparable in other clinical-demographic data and in genetic, serological, and histological findings. Short-term gluten challenge provoked vomiting/nausea in 14/74 (19%) patients. They consumed gluten-free oats less often than those without these symptoms (64% vs. 92%, p = 0.017), whereas the groups did not differ in clinical-demographic features at diagnosis, presence of comorbidities, duration of gluten-free diet, or in other symptoms or grain used ingested during the challenge. According to the literature, prevalence of vomiting/nausea at celiac disease diagnosis has varied 3-46% and during gluten challenge 13-61%. In chronic gluten exposure at celiac disease diagnosis, vomiting was associated with other gastrointestinal symptoms and onset of symptoms already in childhood, whereas regular consumption of oats may increase the tolerance against vomiting/nausea after acute re-exposure in treated celiac disease.
Sections du résumé
BACKGROUND
BACKGROUND
Vomiting and nausea seem to be relatively specific symptoms related to gluten ingestion in treated celiac disease. However, the overall prevalence and associated factors of these symptoms after chronic gluten exposure at celiac disease diagnosis and acute re-exposure during gluten challenge remain obscure.
METHODS
METHODS
Medical data on 815 adult celiac disease patients were collected at diagnosis from the medical records and through supplementary interviews. An additional 74 patients underwent a three-day (10 g/day) gluten challenge (wheat, barley, rye or a combination of the three grains) while in remission. Prevalence of vomiting/nausea and associated factors were evaluated in both cohorts. A literature review was conducted to summarize earlier studies.
RESULTS
RESULTS
Twenty-eight (3%) patients presented with vomiting at diagnosis. They were less often screen-detected and suffered from extra-intestinal symptoms, and had more often abdominal pain (71% vs. 49%, p = 0.021), diarrhea (61% vs. 40%, p = 0.031), weight loss (36% vs. 17%, p = 0.019) and childhood symptoms (61% vs. 33%, p = 0.002) than those without vomiting (n = 787). The groups were comparable in other clinical-demographic data and in genetic, serological, and histological findings. Short-term gluten challenge provoked vomiting/nausea in 14/74 (19%) patients. They consumed gluten-free oats less often than those without these symptoms (64% vs. 92%, p = 0.017), whereas the groups did not differ in clinical-demographic features at diagnosis, presence of comorbidities, duration of gluten-free diet, or in other symptoms or grain used ingested during the challenge. According to the literature, prevalence of vomiting/nausea at celiac disease diagnosis has varied 3-46% and during gluten challenge 13-61%.
CONCLUSIONS
CONCLUSIONS
In chronic gluten exposure at celiac disease diagnosis, vomiting was associated with other gastrointestinal symptoms and onset of symptoms already in childhood, whereas regular consumption of oats may increase the tolerance against vomiting/nausea after acute re-exposure in treated celiac disease.
Identifiants
pubmed: 37674120
doi: 10.1186/s12876-023-02934-w
pii: 10.1186/s12876-023-02934-w
pmc: PMC10481613
doi:
Substances chimiques
Glutens
8002-80-0
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
301Subventions
Organisme : Academy of Finland
ID : 339183 and 347473
Organisme : Academy of Finland
ID : 339183 and 347473
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
J Clin Gastroenterol. 2019 Aug;53(7):507-513
pubmed: 29505551
United European Gastroenterol J. 2020 Feb;8(1):108-118
pubmed: 32213060
Trop Med Int Health. 1998 Jan;3(1):70-5
pubmed: 9484973
Scand J Gastroenterol. 1998 Mar;33(3):251-4
pubmed: 9548617
Int J Mol Med. 2017 Sep;40(3):607-613
pubmed: 28731144
Sci Rep. 2017 Dec 21;7(1):17977
pubmed: 29269859
Clin Transl Gastroenterol. 2012 Feb 16;3:e9
pubmed: 23238134
Nutrients. 2017 Jun 15;9(6):
pubmed: 28617328
Clin Gastroenterol Hepatol. 2008 Feb;6(2):186-93; quiz 125
pubmed: 18096440
Aliment Pharmacol Ther. 2019 Oct;50(8):901-910
pubmed: 31483515
Adv Sci (Weinh). 2021 Jan 04;8(4):2003526
pubmed: 33643806
Eur J Gastroenterol Hepatol. 2020 Nov;32(11):1447-1451
pubmed: 32675775
Nat Rev Dis Primers. 2019 Jan 10;5(1):3
pubmed: 30631077
Br J Nutr. 2014 Oct;112 Suppl 2:S31-43
pubmed: 25267242
Dig Liver Dis. 2018 Nov;50(11):1183-1188
pubmed: 29903545
Aliment Pharmacol Ther. 2020 Jan;51(2):244-252
pubmed: 31769533
J Am Geriatr Soc. 2012 Jun;60(6):1064-9
pubmed: 22690983
Nutr Rev. 2020 May 1;78(5):343-363
pubmed: 31638148
Clin Gastroenterol Hepatol. 2013 Feb;11(2):166-71.e1
pubmed: 23063678
Aliment Pharmacol Ther. 2016 Sep;44(6):612-9
pubmed: 27443825
Gastroenterology. 2009 Sep;137(3):834-40, 840.e1-3
pubmed: 19454285
J Pediatr. 2017 Apr;183:115-121.e2
pubmed: 28153477
Eur J Gastroenterol Hepatol. 1999 Oct;11(10):1185-94
pubmed: 10524652
BMJ. 2009 Aug 27;339:b3154
pubmed: 19713235
Nutr J. 2006 Sep 14;5:24
pubmed: 16972991
United European Gastroenterol J. 2018 May;6(4):567-575
pubmed: 29881612
J Family Med Prim Care. 2019 May;8(5):1607-1612
pubmed: 31198723
Middle East J Dig Dis. 2014 Apr;6(2):98-103
pubmed: 24872869
Gastroenterology. 2009 Mar;136(3):816-23
pubmed: 19111551
Dig Dis. 2015;33(2):141-146
pubmed: 25925915
Aliment Pharmacol Ther. 2013 Jan;37(2):252-62
pubmed: 23163616
Gastroenterology. 2018 Feb;154(3):529-539.e2
pubmed: 29102613
World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):207-12
pubmed: 26558154
Nutrients. 2013 Nov 19;5(11):4614-41
pubmed: 24284613
Sci Adv. 2019 Aug 07;5(8):eaaw7756
pubmed: 31457091
J Coll Physicians Surg Pak. 2013 Jul;23(7):522-4
pubmed: 23823965
J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):48-52
pubmed: 28514243
Gastroenterol Clin Biol. 2008 Mar;32(3):236-42
pubmed: 18359595
Gastroenterology. 2014 Jun;146(7):1649-58
pubmed: 24583059
Am J Gastroenterol. 2011 Jul;106(7):1333-9
pubmed: 21364545
Am J Gastroenterol. 2022 Feb 1;117(2):319-326
pubmed: 34797778
Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(7):691-700
pubmed: 37243608
Gastroenterology. 2022 Dec;163(6):1510-1521.e6
pubmed: 35931103
Sci Transl Med. 2010 Jul 21;2(41):41ra51
pubmed: 20650871
J Invest Dermatol. 2019 Oct;139(10):2108-2114
pubmed: 30998982
J Gastrointestin Liver Dis. 2013 Dec;22(4):391-6
pubmed: 24369320
Aliment Pharmacol Ther. 2022 Jul;56 Suppl 1:S64-S72
pubmed: 35815828
Gerontology. 2001 Nov-Dec;47(6):306-10
pubmed: 11721143
N Engl J Med. 2021 Jul 1;385(1):35-45
pubmed: 34192430
Postgrad Med J. 2007 Apr;83(978):273-6
pubmed: 17403956
Arch Med Res. 2019 Oct;50(7):437-441
pubmed: 31785504
Dig Dis Sci. 2003 Apr;48(4):761-4
pubmed: 12741468
Nutrients. 2019 Jul 25;11(8):
pubmed: 31349675
Dig Liver Dis. 2016 May;48(5):499-505
pubmed: 26854256
BMC Med. 2020 Nov 26;18(1):362
pubmed: 33239013
Nutrients. 2022 Aug 04;14(15):
pubmed: 35956368